封面
市場調查報告書
商品編碼
1404992

感染控制市場規模、佔有率、趨勢分析報告:按類型、最終用途、按地區、細分市場預測,2023-2030 年

Infection Control Market Size, Share & Trends Analysis Report By Type, By End-use, By Region, And Segment Forecasts, 2023 - 2030

出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

感染控制市場的成長與趨勢:

Grand View Research, Inc. 的最新報告顯示,到 2030 年,全球感染控制市場規模預計將達到 3,596 億美元。

預計2023年至2030年市場複合年成長率為6.7%。人們對全球醫院感染大幅增加的日益擔憂推動了市場的發展。據信這會增加感染控制產品的普及。新生技藥品的開拓以及隨之而來的無菌產品需求的增加是整個市場的主要成長要素。醫療保健組織致力於實施對可能引起公共衛生問題的疾病事件進行早期識別、報告、隔離和監測的策略。

此外,針對護理人員和其他醫護人員的感染預防和控制強化訓練模組數量的增加表明,感染控制產品可能在未來幾年廣泛使用。例如,安大略護理學院發布了標準實踐指南,重點關注保持手部衛生,以減少污染和感染傳播。此外,美國疾病管制與預防中心 (CDC) 還發布了消毒和滅菌指南,以幫助醫療保健專業人員在各種醫療機構(包括門診居家醫療和醫院)中有效使用感染控制產品。

受上述因素影響,感染防治產品的整體普及預計將顯著提高,預計將推動市場需求和收益達到前所未有的高度。阻止 COVID-19 傳播的需求也推動了感染控制的需求。政府當局製定了保護公眾健康和防止交叉感染的準則和政策。 CDC 和美國衛生與公眾服務部發布了關於基本感染控制和預防、設備相關感染、抗生素抗藥性、疾病/生物體特異性感染和手術相關感染的廣泛指南,以促進醫院感染的控制。我們提供一個圖書館。

公司不斷增加的策略性舉措(例如策略合作夥伴關係、併購和產品開拓)正在進一步推動市場成長。例如,Getinge擴大了與XPO Logistics的合作關係,XPO Logistics將於2021年2月為Getinge的感染控制業務部門提供從荷蘭到EMEA地區的倉儲和運輸服務。

感染控制市場報告亮點

  • 隨著第三方洗消商變得更加突出以及外包滅菌變得更具成本效益,預計服務將呈指數級成長。
  • 由於控制醫院感染增加的臨床緊迫性,到 2022 年,醫院將佔很大比例。
  • 隨著醫院、醫療設備製造商和製藥公司正在實施大規模的感染預防工作,到 2022 年,北美將佔據整個市場的壓倒性佔有率。
  • 由於人們對醫療環境中感染傳播和預防措施的認知不斷提高,預計亞太市場在預測期內將出現指數級成長。
  • 競爭格局的特徵是公司採取地理擴張和併購等永續性策略,導致市場佔有率大幅成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章感染控制市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 感染控制市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章感染控制市場:類型估計與趨勢分析

  • 感染控制市場:重點
  • 感染控制市場:2022 年和 2030 年趨勢和市場佔有率分析
  • 裝置
    • 2018-2030 年設備市場估計與預測
    • 消毒劑
    • 滅菌設備
    • 其他
    • 服務
    • 2018-2030 年服務市場估計與預測
    • 合約滅菌
    • 感染性廢棄物的處置
  • 消耗品
    • 2018-2030 年消耗品市場估計與預測
    • 感染性廢棄物的處置
    • 消毒劑
    • 無菌消耗品
    • 個人防護設備
    • 其他

第5章感染控制市場:最終用途估計與趨勢分析

  • 感染控制市場:重點
  • 感染控制市場:2022 年和 2030 年趨勢和市場佔有率分析
  • 醫院
    • 2018-2030 年醫院市場估計與預測
  • 醫療設備公司
    • 2018-2030年醫療設備公司的市場估計與預測
  • 臨床檢查
    • 2018-2030 年臨床檢測市場估計與預測
  • 製藥公司
    • 2018年至2030年製藥公司市場預測
  • 其他
    • 2018-2030 年其他市場估計與預測

第6章感染控制市場:區域估計與趨勢分析

  • 區域展望
  • 按地區分類的感染控制市場:要點
  • 北美洲
    • 2018-2030 年北美市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 2018-2030 年歐洲市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 2018-2030 年亞太市場估計與預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市場估計與預測
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 2018年至2030年中東和非洲市場估計和預測
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第7章競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
    • 3M
    • Belimed AG
    • O&M Halyards or its affiliates.
    • Getinge
    • ASP
    • Sterigenics US, LLC - A Sotera Health company
    • MMM Group
    • Cantel Medical Corp.
    • STERIS PLC
    • Midmark Corporation.
    • Medivators Inc.
    • W&H
Product Code: GVR-1-68038-822-0

Infection Control Market Growth & Trends:

The global infection control market size is expected to reach USD 359.6 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 6.7% from 2023 to 2030. The market is driven by rising concerns with respect to a significant upsurge in hospital-acquired infections globally. This is believed to facilitate greater penetration of infection control products. An influx in the development of new biologics and subsequent demand for sterilized formulations serve as key growth factors for the overall market. Healthcare organizations are focused on implementing strategies for early recognition, reporting, isolation, and surveillance of disease episodes of potential public health concern.

In addition, an increasing number of intensive training modules, for nurses and other medical staff, on infection prevention and control is presumed to provide high potential for extensive usage of infection control products over the coming years. For instance, College of Nurses of Ontario released guidelines concerning standard practices, that is focused on maintaining hand hygiene to reduce contamination and spread of infection. Furthermore, Centers for Disease Control and Prevention (CDC) has released guidelines for disinfection and sterilization for efficient usage of infection control products by healthcare personnel in a wide array of healthcare settings such as ambulatory care, home care, hospitals, and others.

As a consequence of the aforementioned factors, it is presumed that there will be a significant improvement in the overall penetration rate of infection prevention and control products, which is also anticipated to fuel the market demand as well as the revenue to unprecedented heights. The demand for infection control also stemmed from the need to stop the spread of COVID-19. Governments' authorities prescribed guidelines and policies to safeguard public health and prevent cross-contamination. The CDC, and the U.S. Department of Health and Human Services, provide an extensive library of guidelines on basic infection control and prevention, device-associated infections, antibiotic resistance, disease / organism-specific infection, and procedure-associated infections to promote the control of hospital-acquired infections.

Increase in strategic initiatives undertaken by companies including include strategic partnerships, mergers and acquisitions, and product development are further propelling the market growth. For instance, Getinge expanded its partnership with XPO Logistics under which the latter will provide warehousing and transport services from the Netherlands to the EMEA region for the company's infection control business unit in February 2021.

Infection Control Market Report Highlights:

  • Services are predicted to observe exponential growth as a consequence of the increasing presence of third-party reprocessors and outsourcing of sterilization as a result of associated cost-efficiency
  • Hospitals accounted for a substantial share in 2022, as a consequence of high clinical urgency to curb the growing incidence of hospital-acquired infections
  • North America captured a dominant share of the overall market as of 2022 owing to extensive infection prevention activities being implemented in hospitals, medical device,s and pharmaceutical companies
  • The market in Asia Pacific is projected to witness exponential growth during the forecast period as a result of increasing awareness pertaining to the spread of infections within healthcare settings and measures for prevention
  • The competitive environment is marked by companies adopting sustainability strategies such as geographical expansion and mergers and acquisitions resulting in significant growth in their market share

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. End use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional scope
  • 2.3. Competitive Insights

Chapter 3. Infection Control Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Infection Control Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Infection Control Market: Type Estimates & Trend Analysis

  • 4.1. Infection Control Market: Key Takeaways
  • 4.2. Infection Control Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Equipment
    • 4.3.1. Equipment market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.2. Disinfectors
      • 4.3.2.1. Disinfectors market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.2.2. Washers
      • 4.3.2.2.1. Washers market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.2.3. Flushers
      • 4.3.2.3.1. Flushers market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.2.4. Endoscope reprocessors
      • 4.3.2.4.1. Endoscope reprocessors market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.3. Sterilization equipment
      • 4.3.3.1. Sterilization equipment market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.3.2. Heat sterilization equipment
      • 4.3.3.2.1. Heat sterilization equipment market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.3.3. Low-temperature equipment
      • 4.3.3.3.1. Low-temperature equipment market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.3.4. Radiation sterilization equipment
      • 4.3.3.4.1. Radiation sterilization equipment market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.3.5. Filtration sterilization equipment
      • 4.3.3.5.1. Filtration sterilization equipment market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.3.6. Liquid sterilization equipment
      • 4.3.3.6.1. Liquid sterilization equipment market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.4. Others
      • 4.3.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.5. Services
    • 4.3.6. Services market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.7. Contract sterilization
      • 4.3.7.1. Contract sterilization market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.7.2. Ethylene oxide sterilization
      • 4.3.7.2.1. Ethylene oxide sterilization market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.7.3. E-Beam sterilization
      • 4.3.7.3.1. E-Beam sterilization market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.7.4. Gamma sterilization
      • 4.3.7.4.1. Gamma sterilization market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.7.5. Others
      • 4.3.7.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.8. Infectious waste disposal
      • 4.3.8.1. Infectious waste disposal market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.4. Consumables
    • 4.4.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.2. Infectious waste disposal
      • 4.4.2.1. Infectious waste disposal market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.3. Disinfectants
      • 4.4.3.1. Disinfectants market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.4. Sterilization consumables
      • 4.4.4.1. Sterilization consumables market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.5. Personal protective equipment
      • 4.4.5.1. Personal protective equipment market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.6. Others
      • 4.4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Infection Control Market: End Use Estimates & Trend Analysis

  • 5.1. Infection Control Market: Key Takeaways
  • 5.2. Infection Control Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals
    • 5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.4. Medical Device Companies
    • 5.4.1. Medical devices companies market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.5. Clinical Laboratories
    • 5.5.1. Clinical laboratories market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.6. Pharmaceutical Companies
    • 5.6.1. Pharmaceutical companies market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 6. Infection Control Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Infection Control Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. UK
      • 6.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. France
      • 6.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. China
      • 6.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. India
      • 6.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Mexico
      • 6.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.4. Argentina
      • 6.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. 3M
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Belimed AG
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. O&M Halyards or its affiliates.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Getinge
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. ASP
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Sterigenics U.S., LLC - A Sotera Health company
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. MMM Group
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Cantel Medical Corp.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. STERIS PLC
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Midmark Corporation.
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Medivators Inc.
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. W&H
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 3 North America infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 4 North America infection control market, by region, 2018 - 2030 (USD Billion)
  • Table 5 U.S. infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 6 U.S. infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 7 Canada infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 8 Canada infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 9 Europe infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 10 Europe infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 11 Europe infection control market, by region, 2018 - 2030 (USD Billion)
  • Table 12 Germany infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 13 Germany infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 14 UK infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 15 UK infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 16 France infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 17 France infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 18 Italy infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 19 Italy infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 20 Spain infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 21 Spain infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 22 Sweden infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 23 Sweden infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 24 Norway infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 25 Norway infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 26 Denmark infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 27 Denmark infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 28 Asia Pacific infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 29 Asia Pacific infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 30 Asia Pacific infection control market, by region, 2018 - 2030 (USD Billion)
  • Table 31 China infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 32 China infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 33 Japan infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 34 Japan infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 35 India infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 36 India infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 37 Australia infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 38 Australia infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 39 Thailand infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 40 Thailand infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 41 South Korea infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 42 South Korea infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 43 Latin America infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 44 Latin America infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 45 Latin America infection control market, by region, 2018 - 2030 (USD Billion)
  • Table 46 Brazil infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 47 Brazil infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 48 Mexico infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 49 Mexico infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 50 Argentina infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 51 Argentina infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 52 Middle East and Africa infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 53 Middle East and Africa infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 54 Middle East and Africa infection control market, by region, 2018 - 2030 (USD Billion)
  • Table 55 South Africa infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 56 South Africa infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 57 Saudi Arabia infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 58 Saudi Arabia infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 59 UAE infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 60 UAE infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 61 Kuwait infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 62 Kuwait infection control market, by end use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Infection control: market outlook
  • Fig. 9 Infection control competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Infection control market driver impact
  • Fig. 15 Infection control market restraint impact
  • Fig. 16 Infection control market strategic initiatives analysis
  • Fig. 17 Infection control market: Type movement analysis
  • Fig. 18 Infection control market: Type outlook and key takeaways
  • Fig. 19 Equipment market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 20 Disinfectors market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 21 Washers market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 22 Flushes market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 23 Endoscope reprocessors market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 24 Sterilization equipment market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 25 Heat sterilization equipment market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 26 Low temperature equipment market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 27 Radiation sterilization equipment market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 28 Filtration sterilization equipment market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 29 Liquid sterilization equipment market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 31 Service market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 32 Contract sterilization market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 33 Ethylene oxide sterilization market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 34 E-beam sterilization market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 35 Gamma sterilization market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 36 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 37 Waste disposal market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 38 Consumables market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 39 Infectious waste disposal market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 40 Disinfectants market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 41 Sterilization consumables market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 42 Personal protective equipment market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 43 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Infection control market: End use movement analysis
  • Fig. 45 Infection control market: End use outlook and key takeaways
  • Fig. 46 Hospitals market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 47 Medical device companies market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 48 Clinical laboratories market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 49 Pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 50 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 51 Infection control market: Regional movement analysis
  • Fig. 52 Infection control market: Regional outlook and key takeaways
  • Fig. 53 North America market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 U.S. market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 55 Canada market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 56 Europe market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 57 UK market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 58 Germany market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 59 France market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 60 Italy market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 61 Spain market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 62 Sweden market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 63 Norway market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 64 Denmark market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 65 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 66 Japan market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 67 China market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 68 India market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 69 Australia market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 70 Thailand market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 71 South Korea market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 72 Latin America market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 73 Brazil market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 74 Mexico market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 75 Argentina market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 76 MEA market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 77 South Africa market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 78 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 79 UAE market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 80 Kuwait market estimates and forecasts, 2018 - 2030 (USD Billion)